Current Status of Clinical Trials on Tau Immunotherapies Changyi JiEinar M. Sigurdsson Leading Article 08 June 2021 Pages: 1135 - 1152
Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions Eric Y LinPaul C AdamsonJeffrey D. Klausner Review Article Open access 07 June 2021 Pages: 1153 - 1169
Neurokinin-1 Antagonists for Postoperative Nausea and Vomiting Zhaosheng JinNeil DakslaTong J. Gan Review Article 09 June 2021 Pages: 1171 - 1179
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents Sho HasegawaMasato YonedaAtsushi Nakajima Review Article Open access 17 June 2021 Pages: 1181 - 1192
Remimazolam: A Review in Procedural Sedation Arnold LeeMatt Shirley Adis Drug Evaluation 01 July 2021 Pages: 1193 - 1201
Bupivacaine/Meloxicam Prolonged Release: A Review in Postoperative Pain Hannah A. Blair Adis Drug Evaluation 06 July 2021 Pages: 1203 - 1211
Fuzuloparib: First Approval Arnold Lee AdisInsight Report Open access 12 June 2021 Pages: 1221 - 1226
Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments Matthew T. RoeBray Patrick-LakeAndrew C. von Eschenbach Letter to the Editor 16 June 2021 Pages: 1235 - 1237
Correction to: Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC James E. Frampton Correction Open access 28 May 2021 Pages: 1239 - 1239
Correction to: Lazertinib: First Approval Sohita Dhillon Correction Open access 09 June 2021 Pages: 1241 - 1241
